Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy and Safety of Dolutegravir-based Dual Therapies in HIV-infected Patients With Intolerance or Toxicity to Nucleoside Analogues

NCT02491242 is registered in ClinicalTrials.gov with Asociacion para el Estudio de las Enfermedades Infecciosas as lead sponsor.

NCT NCT02491242
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02491242 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy and Safety of Dolutegravir-based Dual Therapies in HIV-infected Patients With Intolerance or Toxicity to Nucleoside Analogues
Lead sponsor
Asociacion para el Estudio de las Enfermedades Infecciosas
Phase
Observational
Overall status
Completed
Start date
November 30, 2015
Completion date
June 30, 2018
Enrollment
155 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infection